Medplus Health Services Ltd share price logo

Medplus Health Services Ltd Share Price

(MEDPLUS)

₹750.551.24%

as on 04:01PM, 01 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Medplus Performance

  • Day's Low

    Day's High

    ₹745.5
    Day's Price Range
    ₹778.3
  • 52 Week's Low

    52 Week's High

    ₹616
    52-Week Price Range
    ₹875.65
1 Month Return+ 4.92 %
3 Month Return-10.43 %
1 Year Return+ 8.88 %
Previous Close₹760.00
Open₹760.00
Volume1.08L
Upper Circuit₹912.00
Lower Circuit₹608.00
Market Cap₹9,096.73Cr

Medplus Fundamentals

P/E Ratio

68.53

PEG Ratio

11.13

Market Cap

₹9,096.73 Cr

P/B Ratio

7.03

EPS

5.49

Dividend Yield

0

Sector

Retail

ROE

0.75

Medplus Analyst Rating

based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts offering long term price targets for Medplus. An average target of ₹964.5

Source: S&P Global Market Intelligence

Medplus Share analysis

Medplus price forecast by 6 analysts

Upside of26.91%

High

₹1160

Target

₹964.50

Low

₹900

Medplus target price ₹964.5, a slight upside of 26.91% compared to current price of ₹750.55. According to 6 analysts rating.

Source: S&P Global Market Intelligence

Key events for Medplus Health Services Ltd

  • MedPlus Subsidiary Faces Drug License Suspensions - 24 Mar, 2025

    MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions in Karnataka and Maharashtra, potentially leading to revenue losses of approximately Rs 10.72 lacs. This regulatory challenge may impact the company's financial operations and market positioning.

Insights on Medplus Health Services Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 18.08% to 21.51% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 14.36 Cr → 45.89 Cr (in ₹), with an average increase of 39.3% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 16.85% to 18.69% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MEDPLUS stock has moved up by 0.6%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 14.72% to 15.23% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Novelix Pharmaceuticals Ltd has given 214.9% return, outperforming this stock by 240.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 40.39% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Novelix Pharmaceuticals Ltd has given 54.8% return, outperforming this stock by 45.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.58K Cr → 1.57K Cr (in ₹), with an average decrease of 0.9% per quarter

Medplus Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,441.47Cr (-)₹1,490.50Cr (↑3.40%)₹1,488.83Cr (↓0.11%)₹1,576.17Cr (↑5.87%)₹1,561.45Cr (↓0.93%)
Net Income₹13.71Cr (-)₹33.56Cr (↑144.78%)₹14.34Cr (↓57.27%)₹38.70Cr (↑169.87%)₹45.87Cr (↑18.53%)
Net Profit Margin0.95% (-)2.25% (↑136.84%)0.96% (↓57.33%)2.46% (↑156.25%)2.94% (↑19.51%)
Value in ₹ crore
Details2021202220232024
Total Assets₹548.42Cr (-)₹1,187.46Cr (↑116.52%)₹1,271.95Cr (↑7.12%)₹1,314.88Cr (↑3.38%)
Total Liabilities₹30.93Cr (-)₹74.68Cr (↑141.45%)₹130.67Cr (↑74.97%)₹142.25Cr (↑8.86%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹0.11Cr (-)-₹6.24Cr (↑5,572.73%)-₹18.37Cr (↑194.39%)₹11.41Cr (↓162.11%)₹7.67Cr (↓32.78%)

Medplus Index Inclusions

S&P BSE 400 MidSmallCap

₹10,682.44

-0.83 (-89.63%)

S&P BSE 250 SmallCap

₹6,015.71

-0.39 (-23.54%)

BSE 500

₹33,153.99

-1.27 (-425.23%)

BSE Small-Cap

₹46,671.93

0.07 (33.8%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Medplus Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
40.39%
0.00
Foreign Institutions
15.23%
3.46
Mutual Funds
21.51%
18.99
Retail Investors
18.69%
10.88
Others
4.19%
-57.97

Medplus Key Indicators

Details202220232024
Return On Equity %0.630.440.75
Details20202021202220232024
Return On Assets %0.5311.648.073.914.98
Details202220232024
Book Value Per Share (₹)118.84124.99132.01
Details202220232024
Earning Per Share (₹)7.944.25.49

Medplus Valuation

Medplus in the last 5 years

  • Overview

  • Trends

Lowest (62.62x)

March 18, 2025

Industry (-275.86x)

March 28, 2025

Today (68.53x)

March 28, 2025

Highest (263.63x)

March 17, 2023

LowHigh

Medplus Earnings and Dividends

  • Medplus Health Services Ltd Earnings Results

    Medplus Health Services Ltd’s net profit jumped 234.23% since last year same period to ₹45.89Cr in the Q3 2024-2025. On a quarterly growth basis, Medplus Health Services Ltd has generated 18.46% jump in its net profits since last 3-months.

    Read More about Earnings Results

Medplus Technicals Summary

Bearish

Neutral

Bullish

Bullish

Medplus Health Services Ltd is currently in a Bullish trading position according to technical analysis indicators.

Medplus Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹9,096.73 Cr-6.44%0.54₹65 Cr₹5,624 Cr
NA₹20.08 Cr237.04%1.25₹1 Cr₹4 Cr
NA₹1,378.33 Cr31.15%0.56₹81 Cr₹4,828 Cr
NA₹1,201.31 Cr183.67%0.53₹11 Cr₹131 Cr
NA₹7.57 Cr-4.65%0.50-₹1 Cr₹5 Cr

About Medplus

Medplus Health Services Ltd is a leading healthcare solutions provider, incorporated in 2006. Medplus provides a range of products and services across its various lines of business, including retail pharmacy, healthcare services, diagnostic services, and wellness products.

The company's retail pharmacy offers an extensive selection of prescription and over-the-counter medicines, including popular brands such as Pfizer, Novartis, and GlaxoSmithKline. It also stocks a wide range of health and wellness products, including vitamins, supplements, and herbal products.

Medplus also offers a variety of healthcare services, including home nursing, physiotherapy, and medical equipment rental. Its diagnostic services include X-ray, ultrasound, and lab tests. The company also provides health check-up packages and health insurance services.

Revenue: ₹1,561.45Cr as on December 2024 (Q4 24)
Net Profit: ₹45.87Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2021
Chairperson Name: GANGADI MADHUKAR REDDY
OrganisationMedplus
Headquarters
IndustryRetail
E-voting on sharesClick here to vote

FAQs on Medplus Health Services Ltd

What is Medplus Health Services Ltd price today?

Medplus Health Services Ltd share price today stands at ₹750.55, Open: ₹760, Previous Close: ₹760, High: ₹778.3, Low: ₹745.5, 52 Week High: ₹875.65, 52 Week Low: ₹616.

How to Buy Medplus Health Services Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Medplus Health Services Ltd shares

What are today's traded volumes of Medplus Health Services Ltd?

Today's traded volume of Medplus Health Services Ltd(MEDPLUS) is 1.08L.

What is today's market capitalisation of Medplus Health Services Ltd?

Today's market capitalisation of Medplus Health Services Ltd(MEDPLUS) is ₹9096.73Cr.

What is the 52 Week High and Low Range of Medplus Health Services Ltd?

Medplus Health Services Ltd (MEDPLUS)
Price
52 Week High
₹875.65
52 Week Low
₹616

How much percentage Medplus Health Services Ltd is down from its 52 Week High?

Medplus Health Services Ltd (MEDPLUS) share price is ₹750.55. It is down -14.29% from its 52 Week High price of ₹875.65

How much percentage Medplus Health Services Ltd is up from its 52 Week low?

Medplus Health Services Ltd (MEDPLUS) share price is ₹750.55. It is up 21.84% from its 52 Week Low price of ₹616